Pfizer Starts Large Trial For Anti-Covid Pill
Umer Jamshaid Published September 27, 2021 | 08:01 PM
Pfizer said Monday it had begun a middle-to-late stage clinical trial of a pill to stave off Covid in people who are exposed to infection
Washington, (APP - UrduPoint / Pakistan Point News - 27th Sep, 2021 ) :Pfizer said Monday it had begun a middle-to-late stage clinical trial of a pill to stave off Covid in people who are exposed to infection.
Several companies are working on so-called oral antivirals, which would mimic what the drug Tamiflu does for influenza and prevent the disease from progressing to severe.
"We believe that tackling the virus will require effective treatments for people who contract, or have been exposed to, the virus, complementing the impact that vaccines have had," said Mikael Dolsten, the company's chief scientific officer.
Pfizer started developing its drug, called PF-07321332, in March 2020 and is testing it in combination with ritonavir, a repurposed HIV medicine.
The clinical trial will enroll 2,660 adults who will take part at the first signs of Covid infection or at first awareness of exposure.
They will be randomly assigned to receive either a combination of PF-07321332 and ritonavir, or a placebo twice a day for five or ten days.
The objective is to assess the safety and efficacy of the drugs being studied at preventing SARS-CoV-2 infection and symptomatic disease by day 14.
Other companies are also testing existing oral antivirals against Covid -- but Pfizer's is the first specifically designed against the coronavirus.
It is known as a "protease inhibitor" and has been shown in lab testing to jam up the virus' replication machinery.
If it works in real life, it will likely only be effective at the early stages of infection.
By the time Covid progresses to severe disease, the virus has largely stopped replicating and patients suffer from an over-active immune response.
Recent Stories
HEC reviews curricula for environmental sciences degree programme
ICC Asia looking forward to an action-packed Asia Cricket Week
Yuvraj Singh named ICC Men’s T20 World Cup 2024 Ambassador
Greece hands Olympic flame to 2024 Paris Games hosts
Two Kyiv hospitals evacuating over feared Russian strikes
World must act on neurotech revolution, say experts
Charles & Catherine's cancer diagnoses
Champions Alcaraz and Sabalenka through in Madrid Open
King Charles to resume some public duties during cancer treatment: palace
US defense chief announces $6 bn in security aid for Ukraine
Heavy rains cause damage to Spezand-Taftan railway track
Woman stabbed in Israel, attacker killed: police
More Stories From World
-
Junta-led Burkina Faso suspends BBC, Voice of America for two weeks
52 minutes ago -
Two Kyiv hospitals evacuating over feared Russian strikes
1 hour ago -
World must act on neurotech revolution, say experts
1 hour ago -
Charles & Catherine's cancer diagnoses
1 hour ago -
King Charles to resume some public duties during cancer treatment: palace
1 hour ago -
US defense chief announces $6 bn in security aid for Ukraine
1 hour ago
-
Woman stabbed in Israel, attacker killed: police
1 hour ago -
Israeli-fired unexploded bombs could take 14 years to clear: UN
1 hour ago -
US announces $6 bn in security aid for Ukraine
1 hour ago -
Pakistan’s National Day Reception held in Colombo
1 hour ago -
Erdogan's White House talks with Biden on May 9 postponed: Turkish official
1 hour ago -
Spanish PM keeps country guessing on his future
1 hour ago